HK1215433A1 - 製備苯並氧氮雜䓬化合物的方法 - Google Patents
製備苯並氧氮雜䓬化合物的方法Info
- Publication number
- HK1215433A1 HK1215433A1 HK16103386.8A HK16103386A HK1215433A1 HK 1215433 A1 HK1215433 A1 HK 1215433A1 HK 16103386 A HK16103386 A HK 16103386A HK 1215433 A1 HK1215433 A1 HK 1215433A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- making
- benzoxazepin compounds
- compounds
- making benzoxazepin
- benzoxazepin
- Prior art date
Links
- ZCXLTWVZYXBHJS-UHFFFAOYSA-N 1,2-benzoxazepine Chemical class O1N=CC=CC2=CC=CC=C12 ZCXLTWVZYXBHJS-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361779619P | 2013-03-13 | 2013-03-13 | |
PCT/EP2014/054786 WO2014140073A1 (fr) | 2013-03-13 | 2014-03-12 | Procédé de fabrication de composés benzoazépines |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1215433A1 true HK1215433A1 (zh) | 2016-08-26 |
Family
ID=50241450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16103386.8A HK1215433A1 (zh) | 2013-03-13 | 2016-03-23 | 製備苯並氧氮雜䓬化合物的方法 |
Country Status (16)
Country | Link |
---|---|
US (1) | US9303043B2 (fr) |
EP (3) | EP3845540A1 (fr) |
JP (6) | JP6363120B2 (fr) |
KR (3) | KR20180070715A (fr) |
CN (2) | CN108929333A (fr) |
AR (1) | AR095365A1 (fr) |
AU (3) | AU2014230812B2 (fr) |
BR (1) | BR112015020716A2 (fr) |
CA (6) | CA3005118A1 (fr) |
HK (1) | HK1215433A1 (fr) |
IL (1) | IL240793A0 (fr) |
MX (1) | MX2015011438A (fr) |
NZ (1) | NZ711192A (fr) |
RU (2) | RU2649976C2 (fr) |
SG (2) | SG11201507394RA (fr) |
WO (1) | WO2014140073A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI638818B (zh) * | 2013-12-16 | 2018-10-21 | 赫孚孟拉羅股份公司 | 2-(4-(2-(1-異丙基-3-甲基-1h-1,2,4-三唑-5-基)-5,6-二氫苯并[f]咪唑并[1,2-d][1,4]氧氮呯-9-基)-1h-吡唑-1-基)-2-甲基丙醯胺之多晶型、製造方法及醫藥用途 |
KR102014326B1 (ko) | 2015-07-02 | 2019-08-26 | 에프. 호프만-라 로슈 아게 | 벤즈옥사제핀 옥사졸리디논 화합물 및 사용 방법 |
CN111848643A (zh) | 2015-07-02 | 2020-10-30 | 豪夫迈·罗氏有限公司 | 苯并氧氮杂*噁唑烷酮化合物及其使用方法 |
CN105906635A (zh) * | 2016-06-08 | 2016-08-31 | 上海大学 | 全氟烷基苯并氮杂*并喹喔啉衍生物及其合成方法 |
US10981877B2 (en) * | 2016-07-29 | 2021-04-20 | Japan Tobacco Inc. | Production method for pyrazole-amide compound |
TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
BR112019010481A2 (pt) | 2016-12-15 | 2019-09-10 | Hoffmann La Roche | processo para a preparação do composto 18 e composto 17 |
CN108752237A (zh) * | 2018-07-05 | 2018-11-06 | 四川青木制药有限公司 | 一种对氨基苯甲脒盐酸盐的新制备方法 |
AU2019407426A1 (en) | 2018-12-21 | 2021-07-22 | Daiichi Sankyo Company, Limited | Combination of antibody-drug conjugate and kinase inhibitor |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6274327B1 (en) | 1992-04-13 | 2001-08-14 | Ludwig Institute For Cancer Research | Polypeptides having kinase activity, their preparation and use |
US5846824A (en) | 1994-02-07 | 1998-12-08 | Ludwig Institute For Cancer Research | Polypeptides having kinase activity, their preparation and use |
GB9208135D0 (en) | 1992-04-13 | 1992-05-27 | Ludwig Inst Cancer Res | Polypeptides having kinase activity,their preparation and use |
BR9914709B1 (pt) * | 1998-10-23 | 2011-09-06 | compostos 3-(fenil substituìdo)-5-(ciclopropil substituìdo)-1,2,4-triazol, seu processo de preparação, composição e processo não terapêutico para controlar insetos ou ácaros. | |
WO2003006151A1 (fr) | 2001-07-12 | 2003-01-23 | Avecia Limited | Catalyseur microencapsule, methodes de preparation et methodes d'utilisation associees |
MXPA04002931A (es) * | 2001-10-12 | 2005-04-11 | Bayer Pharmaceuticals Corp | Heterociclos que contienen nitrogeno de 5 miembros sustituidos con fenilo para el tratamiento de la obesidad. |
US8431695B2 (en) | 2005-11-02 | 2013-04-30 | Bayer Intellectual Property Gmbh | Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases |
PL2081937T3 (pl) * | 2006-10-23 | 2013-01-31 | Sgx Pharmaceuticals Inc | Triazolopirydazynowe modulatory kinaz białkowych |
BRPI0717320A2 (pt) * | 2006-10-23 | 2013-10-22 | Sgx Pharmaceuticals Inc | Triazóis bicíclicos como moduladores de proteína cinase |
ES2531002T3 (es) * | 2007-01-19 | 2015-03-09 | Xcovery Inc | Compuestos inhibidores de quinasa |
CN101909631B (zh) * | 2007-10-25 | 2012-09-12 | 健泰科生物技术公司 | 制备噻吩并嘧啶化合物的方法 |
RU2525389C2 (ru) * | 2008-02-21 | 2014-08-10 | Мерк Шарп И Доум Корп. | Соединения, которые являются ингибиторами erk |
US7928248B2 (en) | 2008-03-31 | 2011-04-19 | Genentech, Inc. | Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use |
GB0810902D0 (en) | 2008-06-13 | 2008-07-23 | Astex Therapeutics Ltd | New compounds |
EP2845592A1 (fr) | 2009-09-28 | 2015-03-11 | F. Hoffmann-La Roche AG | Composés inhibiteurs de PI3K benzoxazepine et procédés d'utilisation |
CN104987345A (zh) | 2009-09-28 | 2015-10-21 | 霍夫曼-拉罗奇有限公司 | 苯并氧杂*pi3k抑制剂化合物和使用方法 |
US9409918B2 (en) * | 2009-10-29 | 2016-08-09 | Merck Sharp & Dohme Corp. | Bridged bicyclic piperidine derivatives and methods of use thereof |
CN102558167A (zh) * | 2010-12-29 | 2012-07-11 | 中国医学科学院药物研究所 | Gk和ppar双重激动活性的噻唑烷二酮衍生物 |
US9090628B2 (en) * | 2011-03-21 | 2015-07-28 | Genentech, Inc. | Benzoxazepin compounds selective for PI3K P110 delta and methods of use |
NO3175985T3 (fr) * | 2011-07-01 | 2018-04-28 | ||
WO2013182668A1 (fr) | 2012-06-08 | 2013-12-12 | F. Hoffmann-La Roche Ag | Sélectivité mutante et associations d'un inhibiteur de phospho‑inositide 3 kinase et agents chimiothérapeutiques pour le traitement du cancer |
-
2014
- 2014-03-12 CA CA3005118A patent/CA3005118A1/fr not_active Abandoned
- 2014-03-12 JP JP2015562108A patent/JP6363120B2/ja active Active
- 2014-03-12 US US14/205,634 patent/US9303043B2/en active Active
- 2014-03-12 CA CA2948763A patent/CA2948763C/fr not_active Expired - Fee Related
- 2014-03-12 AR ARP140100904A patent/AR095365A1/es unknown
- 2014-03-12 RU RU2015138488A patent/RU2649976C2/ru not_active IP Right Cessation
- 2014-03-12 MX MX2015011438A patent/MX2015011438A/es unknown
- 2014-03-12 NZ NZ711192A patent/NZ711192A/en not_active IP Right Cessation
- 2014-03-12 RU RU2018109979A patent/RU2018109979A/ru not_active Application Discontinuation
- 2014-03-12 KR KR1020187016976A patent/KR20180070715A/ko not_active Application Discontinuation
- 2014-03-12 SG SG11201507394RA patent/SG11201507394RA/en unknown
- 2014-03-12 KR KR1020157024484A patent/KR101821468B1/ko active IP Right Grant
- 2014-03-12 WO PCT/EP2014/054786 patent/WO2014140073A1/fr active Application Filing
- 2014-03-12 BR BR112015020716A patent/BR112015020716A2/pt not_active Application Discontinuation
- 2014-03-12 CA CA3005112A patent/CA3005112A1/fr not_active Abandoned
- 2014-03-12 EP EP20204345.1A patent/EP3845540A1/fr active Pending
- 2014-03-12 CA CA2948765A patent/CA2948765A1/fr not_active Abandoned
- 2014-03-12 CN CN201810489045.8A patent/CN108929333A/zh active Pending
- 2014-03-12 CN CN201480015055.8A patent/CN105377856B/zh active Active
- 2014-03-12 CA CA3005103A patent/CA3005103A1/fr not_active Abandoned
- 2014-03-12 EP EP18173513.5A patent/EP3404032A3/fr active Pending
- 2014-03-12 SG SG10201706760YA patent/SG10201706760YA/en unknown
- 2014-03-12 AU AU2014230812A patent/AU2014230812B2/en not_active Ceased
- 2014-03-12 CA CA2897618A patent/CA2897618A1/fr not_active Abandoned
- 2014-03-12 EP EP14709314.0A patent/EP2970329A1/fr not_active Withdrawn
- 2014-03-12 KR KR1020177016062A patent/KR101871133B1/ko active IP Right Grant
-
2015
- 2015-08-24 IL IL240793A patent/IL240793A0/en unknown
-
2016
- 2016-03-23 HK HK16103386.8A patent/HK1215433A1/zh unknown
- 2016-06-28 AU AU2016204432A patent/AU2016204432B2/en not_active Ceased
-
2017
- 2017-07-10 JP JP2017135083A patent/JP6442005B2/ja active Active
-
2018
- 2018-02-27 AU AU2018201393A patent/AU2018201393A1/en not_active Abandoned
- 2018-03-12 JP JP2018044050A patent/JP2018150298A/ja active Pending
- 2018-08-16 JP JP2018153231A patent/JP6663459B2/ja active Active
- 2018-11-22 JP JP2018219226A patent/JP2019089762A/ja active Pending
-
2020
- 2020-02-28 JP JP2020032846A patent/JP2020114814A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201311910D0 (en) | Novel Compounds | |
GB201311888D0 (en) | Novel compounds | |
HK1215433A1 (zh) | 製備苯並氧氮雜䓬化合物的方法 | |
IL243207B (en) | Process for manufacturing 4 -propargylated amino-benzoxazinones | |
GB201317363D0 (en) | Novel compounds | |
HK1211026A1 (en) | Process for making thienopyrimidine compounds | |
GB201318222D0 (en) | Novel compounds | |
GB201314926D0 (en) | Novel Compounds | |
IL245543B (en) | A process for the fluorination of compounds | |
IL241287A0 (en) | Processes for the preparation of subfervir | |
IL245542A0 (en) | A process for the fluorination of compounds | |
GB201415000D0 (en) | Improved process | |
GB201320021D0 (en) | Novel Compounds | |
EP2971018A4 (fr) | Procédé de bioraffinerie à base d'orge | |
EP2970113A4 (fr) | Nouveaux composés | |
GB201316764D0 (en) | Novel compounds | |
GB201316762D0 (en) | Novel compounds | |
GB201306308D0 (en) | Novel process | |
IL244646A0 (en) | Process for preparing 5-fluoro-1-alkyl-3-fluoroalkyl-1h-pyrazole-4-carbaldehyde | |
IL239993A (en) | Process for the preparation of 5-fluoro-1-methyl-3-difluoromethyl-h1-ferrous-4-carbaldehyde | |
GB201307314D0 (en) | Process for preparing chemical compounds | |
GB201321976D0 (en) | Novel compounds | |
GB201321972D0 (en) | Novel compounds | |
GB201321975D0 (en) | Novel compounds | |
GB201321811D0 (en) | Novel compounds |